Butterfly Network (BFLY) Net Margin Growth (3y) (2023 - 2026)

Butterfly Network (BFLY) Net Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 182.32 Bn 175.03 Bn 6.27 Bn -388.00
2 Stryker 128.82 Bn 125.95 Bn 3.81 Bn -1.00
3 Medtronic 108.46 Bn 99.24 Bn 6.41 Bn -108.00
4 Boston Scientific 68.25 Bn 66.79 Bn 3.61 Bn 1,692.00
5 Edwards Lifesciences 47.64 Bn 43.97 Bn 1.29 Bn -
6 Dexcom 28.55 Bn 27.43 Bn 750.30 Mn 1,018.00
7 GE HealthCare Technologies 28.51 Bn 26.22 Bn 1.98 Bn 399.00
8 Smith & Nephew 26.96 Bn 26.39 Bn - -
9 Koninklijke Philips 25.42 Bn 22.29 Bn 2.07 Bn 1,978.00
10 Butterfly Network 1.75 Bn 1.61 Bn 18.29 Mn 16,894.00

Historic Data

Download Data
DateValue
Mar 31, 2026 16,894.00
Dec 31, 2025 12,905.00
Sep 30, 2025 12,095.00
Jun 30, 2025 12,716.00
Mar 31, 2025 21,978.00
Dec 31, 2024 -86.00
Sep 30, 2024 1,044.00
Jun 30, 2024 -5,528.00
Mar 31, 2024 -11,770.00
Dec 31, 2023 -12,059.00
Sep 30, 2023 73,233.00
Jun 30, 2023 4,200.00
Mar 31, 2023 6,418.00